" class="no-js "lang="en-US"> Gene Therapy Archives - Medtech Alert
Monday, April 15, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

Eloxx Pharmaceuticals, a leader in ribosomal RNA-targeted genetic therapies for rare diseases, have announced the […]

Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets

Captivate Bio and EverCell Bio are excited to announce a new collaboration to accelerate the development […]

NIH Approves Second Phase of Funding to Support IND-enabling Work for Ambulero Gene Therapy to Treat Vascular Disease

Ambulero is developing a first-in-class gene and cell therapy platform for treating serious vascular diseases […]

Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy

Charles River Laboratories International and Curigin, a Korean biotechnology company developing innovative oncolytic ribonucleic acid […]

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

Charles River Laboratories International and the INADcure Foundation, a nonprofit organization whose mission is to […]

Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430

Astellas Pharma and Kate Therapeutics have announced an exclusive license agreement to develop and commercialize KT430. […]

Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene Therapy for PKP2 Arrhythmogenic Cardiomyopathy (ACM)

Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]

Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics

Bayer AG is joining forces with Acuitas Therapeutics, a biotechnology company specializing in the development […]

Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome

Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]

RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings

RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more